AU2002354844A1 - Process for manufacturing of tagatose - Google Patents
Process for manufacturing of tagatoseInfo
- Publication number
- AU2002354844A1 AU2002354844A1 AU2002354844A AU2002354844A AU2002354844A1 AU 2002354844 A1 AU2002354844 A1 AU 2002354844A1 AU 2002354844 A AU2002354844 A AU 2002354844A AU 2002354844 A AU2002354844 A AU 2002354844A AU 2002354844 A1 AU2002354844 A1 AU 2002354844A1
- Authority
- AU
- Australia
- Prior art keywords
- galactose
- tagatose
- lactose
- glucose
- temperature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Description
Process for manufacturing of tagatose
Technical field of the invention
The present invention concerns enzymatic manufacturing of tagatose, especially D-tagatose.
Background of the invention
D-Tagatose is a multi-purpose low-calorie bulk sweetener having non-cario- genic and prebiotic properties . D-Tagatose can be used in food and functional food as well as in pharmaceuticals, cf. US 4786722, US 5356879 and US 5447917.
According to US 5002612 and US 5078796 D-tagatose has been manufactured by hydrolyzing lactose or a lactose containing material to a mixture of galactose and glucose using a lactase, optionally removing glucose followed by chemical isomerization of galactose to tagatose.
US 6057135 describes manufacturing of D-tagatose from cheese whey or milk, which is hydrolyzed to prepare a mixture of galactose and glucose. Glucose is separated from the galactose by fermentation of glucose and subjected to isomerization using L-arabinose isomerase.
Summary of the invention
In a first aspect of the invention a process is provided for manufacturing of tagatose comprising a) hydrolyzing lactose or a lactose containing starting
material to obtain galactose and glucose, b) isomehzing the obtained galactose with a L-arabinose isomerase, and c) chromatographic separation of products and unconverted compounds and recycling of unconverted compounds to the process.
In a second aspect of the invention a process is provided, wherein steps a) and b) are performed in one reactor.
In a further aspect of the invention a process is provided for manufacturing of D-tagatose.
In a still further aspect of the invention a process is provided, wherein the L- arabinose isomerase used in step b) is thermophilic.
In a still further aspect of the invention a process is provided, wherein the lactase used in step a) is thermophilic.
In a still further aspect of the invention a process is provided, wherein the temperature used in step(s) a) and/or b) is/are 40 - 90 °C.
Still further aspects of the invention are given in the appended claims.
Brief description of the drawings
Fig. 1 shows the process of example 1 schematically,
Fig. 2 shows the process of example 2 schematically, and Fig. 3 shows the process of example 3 schematically. Fig. 4 shows the result of example 4.
Detailed description of the invention:
It has surprisingly been found that it is possible to use chromatographic separation and recycling in an enzymatic process for manufacturing of tagatose. Thereby higher yields and a cleaner process are achieved. The total yield as well as the yield for each cycle are higher.
Using this process it is possible to recycle and use any unconverted lactose and galactose. It is also possible to separate the products, tagatose and any by-products, especially glucose from galactose and use the glucose for other purposes.
The starting material can be any lactose or lactose containing material.
Lactose is a by-product from the cheese manufacture. This process gives an opportunity to convert lactose, a low-value product produced in excess, into a high value product with properties beneficial to humans. This is a way to use lactose. Opportunities for the utilization of lactose have been sought for a long period of time.
The process involves enzymatic hydrolysis of lactose, enzymatic conversion of galactose into tagatose and optionally chromatographic separation with recycling of non-converted products.
The consumption of chemicals etc is low.
The production of bi-products is low. Only one by-product is produced, viz. glucose as a glucose syrup/powder, which can be used for food.
It is possible to perform the entire reaction in one reactor containing enzymes for the hydrolysis of lactose as well as the isomerization of galactose. Thereby step a) and step b) are combined.
In so doing the complete process is improved in respect of yield per time unit. Galactose is continuously removed from the reactor by isomerization thereof to tagatose, thus reducing the concentration of galactose that would otherwise impede lactase and result in restraint of the transformation of lactose to galactose and glucose. It is possible to carry out the process at high concentration (Brix) because of the high process temperature. Evaporation capacity will be saved which again will result in improved economy as regards investment and working. The increased sugar concentration moreover has the effect that the use of preservatives can be reduced. Also the first chromatographic separation will become superfluous which again means improved economy as regards investment and running.
Especially an enzymatic conversion of lactose to glucose and galactose with subsequent isomerization of the galactose to tagatose in the same enzyme reactor has been demonstrated. The initial tests confirmed that LacS lactase enzyme and L-arabinose isomerase from T. mathranii could function under identical metal ion, buffer and temperature conditions. The principle was then tested by incubation of an 800 mM lactose solution (28%) with immobilized lactase and immobilized isomerase. Samples were analyzed for contents of lactose, glucose, galactose and tagatose by HPLC. During 24 hours of incubation the concentration of glucose increased to about 800 mM indicating that all lactose was cleaved. The concentrations of galactose and tagatose both increased linearly to about 300 mM. Consequently the degree of conversion was (300/800) x 100% = 38%.
The further enzyme can be introduced into the same reactor, a so-called combi-reactor.
The tagatose is especially D-tagatose, which is in high demand in the food industry.
All lactases can be used in step a). Examples are enzymes derived from the group consisting of Bacillus, Sulfolobus, Thermoanaerobacter, Thermus and Pyrococcus.
All L-arabinose isomerases can be used in step b). Examples are enzymes derived from the group consisting of Bacillus, Sulfolobus, Thermoanaerobacter and Thermotoga.
The enzymes can be used in any form. For example is it possible to use immobilized enzymes.
Biotechnological Institute, Denmark, can deliver usable lactases and L- arabinose-isomerases.
Biotechnological Institute, Denmark found and tested an enzyme derived from Thermoanaerobacter mathranii, Thermoanaerobacter mathranii DSM 1 1426. They have filed US patent application no. 09/905, 108 covering their invention.
Km values for T. mathranii enzyme on D-galactose are lower than values for enzymes from common L-arabinose isomerase producing organisms, such as Aerobacter aerogenes, Bacillus amyloliquefaciens, Arthrobacter sp ,and Lactobacillus pentosus. Therefore T. mathranii has a better affinity.
This last mentioned enzyme is thermophilic.
An added benefit of using thermophilic enzymes is the possibility of using high process temperature where the solubility of lactose and glucose is higher. This means that more concentrated products can be used for the enzymatic process of the invention. This again means a less water consump- tion and less water for evaporation. This will give technical advantages and less need for water and energy i.a. for heating and cooling process streams.
The use of thermophilic enzymes has further made it possible to work at a higher temperature. This leads to a better hygiene because of reduced risk of contamination with damaging microorganisms. Furthermore an increased conversion of galactose to tagatose is achieved at higher temperatures compared to the conversion of arabinose to ribulose. In addition hereto there may also be technical advantages such as easier flow and quicker filtration.
It is thus preferred to use enzymes having optimal yields at high temperatures in steps a) and /or in step b). This will normally give a faster reaction. Further, it is possible to clean the system using high temperatures, for example pasteurization temperatures usually used in the dairy industry or temperatures over 100 °C, if the enzymes are thermophilic or even extremophilic. If there is no or only minor temperature difference between the temperature in steps a) and b), the energy for cooling and heating is reduced. The production process can thus be run at temperatures above 60°C. This has wide implications for the microbiology and the consumption of steam and brine for warming and cooling.
The temperature used in step(s) a) and/or b) is/are 40 - 90 °C. Normally it is 60 - 90°C. Preferably the temperature is 60 - 80 °C, more preferably 65- 70 °C, and the most preferred temperature is 65 °C. However, the temperature will depend of the chosen enzymes, and it can be different in steps a) and b). As mentioned above, some advantages are achieved by
using the same temperature in both steps, including performing both steps simultaneously in one reactor.
Contrary to chemical conversion of galactose into tagatose the process can be run at a pH value optimal for sugars. This significantly reduces the production of sugar degradation products. As a result, recovery and economy are improved. A typical pH value is about 7.0. Usable pH values and other reaction parameters are i.a. found in US 6057135. Yamanaka, K and Wood, W. A. (1966) Methods in Enzymology 9: 596-602, list a number of lactic acid bacteria providing an L-arabinose isomerase enzyme capable of producing ketoses from i.a. D-galactose.
The product of the invention in the form of syrup is so pure that it is possible to use tagatose syrups directly. Hitherto it has been necessary to purify the product, for example to crystallize the impure syrup and dissolve or solubilize it again.
As mentioned above, D-Tagatose can be manufactured from a lactose-containing source (e.g. cheese whey, casein whey or milk). Lactose is hydro- lyzed to equal amounts of galactose and glucose by the lactase, which can be immobilized lactase.
Galactose is preferably separated from glucose by chromatography. Non- hydrolyzed lactose may be separated and recycled to the enzyme column. Galactose is isomerized to tagatose by optionally immobilized L-arabinose isomerase. Non-isomerized galactose may be separated by chromatography and recycled. The fraction containing D-Tagatose is crystallized. The crystals are separated from the mother liquor and dried. The mother liquor high in tagatose may be recycled/recrystallized. It is also possible to directly use the tagatose produced as syrup in food products for humans or other purposes.
Thus, there has now been found an effective enzymatic procedure combined with chromatography for manufacturing of tagatose in high yield and in a very pure form in one or two reactors. The process has special advantages if performed with thermophilic/extremophilic enzymes.
The new process for the production of tagatose is highly effective and clean due to a specific enzymatic conversion combined with recycling of non-converted products. The process is extremely effective and environmentally friendly.
EXAMPLES
Example 1
Hydrolysis of lactose with recirculation
Isomerization of galactose with recirculation
1 . Lactose is produced from whey by ultrafiltration followed by crystallization. 2. A solution of lactose in water (8-40%DS) is hydrolyzed by immobilized lactase at high or low temperature (either by enzyme from Aspergillus oryzae or a thermophilic organism).
3. Glucose and galactose are separated by chromatography. Depending on concentration of feed it may be necessary to concentrate for in- stance by evaporation.
4. Lactose and possible gaiactooligosaccharides are recycled to the column containing immobilized enzyme.
5. If the concentration of oligosaccharides in the recycling loop is too high (the hydrolysis is undesirably affected), the system is flushed.
6. The fraction containing glucose and galactose is isomerized by immobilized galactose isomerase (from a thermophilic organism)
7. The mixture is concentrated for instance by evaporation
8. Tagatose is separated by chromatography 9. The tagatose fraction is concentrated and possibly crystallized
10. The glucose fraction might be concentrated for sale as a syrup or it may be further processed
11. The Galactose fraction is recycled to the isomerase column
Example 2
Hydrolysis of lactose without recirculation with following isomerization
1. Lactose is produced from whey by ultrafiltration followed by crystallization.
2. A solution of lactose in water (8-40%DS) is hydrolyzed by immobilized lactase (the enzyme originates from Aspergillus oryzae).
3. The mixture containing about 46% of glucose, 46% of galactose is passed through a column containing immobilized galactose isomerase
(from a thermophilic organism). About 30% of galactose is converted into tagatose.
4. The product is separated into 3 fractions by concentration and chromatographic separation: • Fraction 1 contains mainly non-converted galactose. This fraction is recycled to the galactose isomerase column
• Fraction 2 contains mainly tagatose. This fraction is concentrated for crystallization or it is marketed as syrup.
• Fraction 3 contains mainly glucose, but also galacto- oligosaccharides produced by the lactase enzyme as well as
un-converted lactose, This fraction is concentrated for sale as syrup or for further processing, such as crystallization or drying.
Example 3
Hydrolysis and isomerization in one reactor
1. Lactose is produced from whey by ultrafiltration followed by crystallization. 2. A solution of lactose in water is passed through a column containing immobilized lactase and L-arabinose isomerase (both enzymes originating from thermophilic organisms). 3. The product is separated into 3 fractions by concentration and chromatographic separation: • Fraction 1 contains mainly non-converted galactose. This fraction is recycled to the column for enzymatic conversion.
• Fraction 2 contains mainly tagatose. This fraction is concentrated for crystallization or it is marketed as a syrup.
• Fraction 3 contains mainly glucose, but also galacto- oligosaccharides produced by the lactase enzyme as well as un-converted lactose. This fraction is concentrated for sale as a syrup or for further processing, such as crystallization or drying
Example 4
One-reactor conversion of lactose to tagatose with immobilized lactase and immobilized isomerase
The β-glycosidase encoding gene from Sulfolobus solfataricus (Moracci M, Ciaramella M, and Rossi M. [2001 ] Methods in Enzymology vol. 330, p. 201 - 15) was cloned and expressed in E. coli. The gene was isolated by
polymerase chain reaction (PCR) using purified chromosomal DNA from Sulfolobus solfataricus strain P2. Primers containing additional restriction sites for /Vote I and BamH\ were designed to yield the entire coding sequence on a fragment which was subsequently cloned into the standard expression plasmid pET3a (Novagen).
E. coli cells expressing the enzyme were cultivated, harvested by centrifugation, lysed in a French pressure cell and cross-linked with glutaraldehyde and polyethylenimine as described in US 4,354,105. The immobilized enzyme was recovered by centrifugation and lyophilisation of the pellet. The activity of the immobilized lactase was 1500 units/g dry weight. One unit was defined as the amount of enzyme liberating one micromole of glucose per min at 65°C, pH 7, in a 30-% (w/v) solution of lactose.
The L-arabinose isomerase gene from Thermoanaerobacter mathranii was cloned and expressed in E. coli as described in patent application no. US 09/905.108 (Biotechnological Institute, Denmark).
E. coli cells expressing the enzyme were cultivated, harvested by centrifugation, lysed in a French pressure cell and cross-linked with glutaraldehyde and polyethylenimine as described in US 4,354,105. The immobilized enzyme was recovered by centrifugation and lyophilisation of the pellet. The activity of the immobilized L-arabinose isomerase was 50 units/g dry weight. One unit was defined as the amount of enzyme producing one micromole of D-tagatose per min at 65°C, pH 7, in a 30-% (w/v) solution of D- galactose.
One-milliliter assay mixtures containing 20 mg of immobilized lactase, 80 mg of immobilized isomerase, 0.30 g of lactose (30%, 875 mM), 25 mM K- maleate buffer, pH 6.9, and 5 mM MnCI2 were incubated at 65°C. A control
sample without enzymes was treated similarly. Periodically, samples were taken and the concentrations of glucose, galactose and tagatose were determined by high pressure liquid chromatography using an Aminex HPX- 87C column (Bio-Rad) and a refractive index detector (Waters 410). The mobile phase was de-ionized, degassed water, the column temperature was 85°C, and the flow rate was 0.6 ml/min.
As shown in Figure 4, the concentration of glucose increased to about 800 mM over 24h, indicating that almost all lactose was hydrolyzed to galactose and glucose. The concentration of tagatose increased linearly to about 300 mM over 24h, indicating a bioconversion of 300mM/800 mM = 38%.
TABLE
Conversion of lactose to tagatose with immobilized lacS lactase from S. solfataricus and araA isomerase from T. mathranii
Claims (18)
1. A process for manufacturing of tagatose comprising
a) hydrolyzing lactose or a lactose containing starting material to obtain galactose and glucose
b) isomerizing the obtained galactose with a L-arabinose isomerase, and
c) chromatographic separation of products and unconverted compounds and recycling of unconverted compounds to the process.
2. A process of claim 1 , wherein unconverted lactose is separated by chromatography and recycled to step a) for hydrolysis.
3. A process of claim 1 or 2, wherein unconverted galactose is separated by chromatography and recycled to step b) for isomerization.
4. A process of any of the preceding claims, wherein step a) and step b) are performed in one reactor.
5. A process of any of the preceding claims, wherein the galactose is D- galactose and the tagatose is D-tagatose.
6. A process of any of the preceding claims, wherein the L-arabinose isomerase used in step b) is thermophilic.
7. A process of any of the preceding claims, wherein the lactase used in step a) is thermophilic.
8. A process of claim 1 or 2 wherein the L-arabinose isomerase used in step b) is derived from the group consisting of but not restricted to Bacillus, Sulfolobus, Thermoanaerobacter and Thermotoga.
9. A process of claim 8, wherein the L-arabinose isomerase is derived from Thermoanaerobacter mathranii.
10. A process of claim 9 wherein the L-arabinose isomerase is derived from Thermoanaerobacter mathranii DSM 11426.
11. A process of any of the preceding claims, wherein the lactase used in step a) is derived from the group consisting of but not restricted to Bacillus, Sulfolobus, Thermoanaerobacter, Thermus and Pyrococcus.
12. A process of claim 1 , wherein one or more of the used enzymes is immobilized.
13. A process of any of the preceding claims, wherein the temperature used in step(s) a) and/or b) is/are 40 - 90 °C.
14. A process of claim 13, wherein the temperature is 60 - 90°C.
15. A process of claim 14, wherein the temperature is 60 - 80 °C.
16. A process of claim 15, wherein the temperature is 65 - 70 °C.
17. A process of claim 16, wherein the temperature is 65 °C.
18. A process according to claim 4, wherein the L-arabinose isomerase used is derived from Thermoanaerobacter mathranii and the lactase used is derived from Sulfolobus solfataricus.
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US90510801A | 2001-07-16 | 2001-07-16 | |
US30515501P | 2001-07-16 | 2001-07-16 | |
DKPA200101114 | 2001-07-16 | ||
US09/905,108 | 2001-07-16 | ||
US60/305,155 | 2001-07-16 | ||
DKPA200101114 | 2001-07-16 | ||
PCT/DK2002/000497 WO2003008617A1 (en) | 2001-07-16 | 2002-07-15 | Process for manufacturing of tagatose |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2002354844A1 true AU2002354844A1 (en) | 2003-05-22 |
AU2002354844B2 AU2002354844B2 (en) | 2006-05-25 |
Family
ID=42632538
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002354844A Ceased AU2002354844B2 (en) | 2001-07-16 | 2002-07-15 | Process for manufacturing of tagatose |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1407037B1 (en) |
JP (1) | JP2004535205A (en) |
KR (1) | KR100697762B1 (en) |
AR (1) | AR036169A1 (en) |
AT (1) | ATE315099T1 (en) |
AU (1) | AU2002354844B2 (en) |
BR (1) | BR0211148A (en) |
CA (1) | CA2454277C (en) |
DE (1) | DE60208562T2 (en) |
DK (1) | DK1407037T3 (en) |
ES (1) | ES2256500T3 (en) |
PT (1) | PT1407037E (en) |
WO (1) | WO2003008617A1 (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7357928B2 (en) | 2002-04-08 | 2008-04-15 | University Of Louisville Research Foundation, Inc. | Method for the diagnosis and prognosis of malignant diseases |
WO2009066127A1 (en) * | 2007-11-23 | 2009-05-28 | Institut National De La Recherche Agronomique (Inra) | L-arabinose isomerase for converting d-galactose into d-tagatose in a dairy product which contains d-galactose |
US9139856B2 (en) * | 2008-03-12 | 2015-09-22 | Tata Chemicals Ltd. | Process for production of galactooligosaccharides (GOS) |
US9301540B2 (en) | 2008-06-09 | 2016-04-05 | Georgia-Pacific Panel Products Llc | Prebiotic composition and methods of making and using the same |
WO2011031531A2 (en) | 2009-08-27 | 2011-03-17 | Temple-Inland | Methods of making and using a ruminant gas reduction composition |
EP2501800A4 (en) | 2009-11-17 | 2013-05-22 | Musc Found For Res Dev | Human monoclonal antibodies to human nucleolin |
WO2011072051A2 (en) | 2009-12-08 | 2011-06-16 | Temple-Inland | Nutritional composition and methods of making and using same |
MX2012012873A (en) * | 2010-05-05 | 2013-02-11 | Pepsico Inc | Use of whey for the manufacture of erythritol. |
PL3446714T3 (en) | 2011-06-02 | 2021-11-22 | University Of Louisville Research Foundation, Inc. | Anti-nucleolin agent-conjugated nanoparticles |
KR20130073674A (en) | 2011-12-23 | 2013-07-03 | 씨제이제일제당 (주) | Sterilizing process using a polyethylene glycol nonionic surfactant, and the sterilized microbial cell |
US8802843B2 (en) * | 2012-05-22 | 2014-08-12 | Orochem Technologies, Inc. | Tagatose production using simulated moving bed separation |
HUE046414T2 (en) * | 2013-06-05 | 2020-02-28 | Cj Cheiljedang Corp | Production method for tagatose |
US9150938B2 (en) * | 2013-06-12 | 2015-10-06 | Orochem Technologies, Inc. | Tagatose production from deproteinized whey and purification by continuous chromatography |
WO2015016544A1 (en) | 2013-07-29 | 2015-02-05 | 건국대학교 산학협력단 | Aldolase, aldolase mutant, and method and composition for producing tagatose by using same |
KR101638024B1 (en) | 2014-10-22 | 2016-07-20 | 씨제이제일제당(주) | Composition for preparation of tagatose and manufacturing method for tagatose from fructose |
EP3291839A1 (en) | 2015-05-05 | 2018-03-14 | The University of Louisville Research Foundation, Inc. | Anti-nucleolin agent-conjugated nanoparticles as radio-sensitizers and mri and/or x-ray contrast agents |
CN109790524B (en) * | 2016-06-30 | 2022-07-26 | Cj第一制糖株式会社 | Novel thermotolerant phosphatase specific to tagatose-6-phosphate and method for producing tagatose using same |
EP3731655A1 (en) * | 2017-12-29 | 2020-11-04 | Euroserum | Carbohydrate composition, process for producing the composition and feed and food products comprising such a composition |
CN107974474B (en) * | 2018-01-09 | 2020-11-20 | 山东大学 | Method for producing D-tagatose |
CN115868534A (en) * | 2022-10-18 | 2023-03-31 | 齐鲁工业大学 | Preparation method of sweet milk |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5002612A (en) * | 1989-07-19 | 1991-03-26 | Biospherics Incorporated | Process for manufacturing tagatose |
US6057135A (en) * | 1992-01-16 | 2000-05-02 | Kraft Foods, Inc. | Process for manufacturing D-tagatose |
JP3252295B2 (en) * | 1992-10-08 | 2002-02-04 | 株式会社林原生物化学研究所 | Method for producing L-galactose |
-
2002
- 2002-07-15 AT AT02750839T patent/ATE315099T1/en not_active IP Right Cessation
- 2002-07-15 JP JP2003514933A patent/JP2004535205A/en active Pending
- 2002-07-15 PT PT02750839T patent/PT1407037E/en unknown
- 2002-07-15 CA CA002454277A patent/CA2454277C/en not_active Expired - Fee Related
- 2002-07-15 DE DE60208562T patent/DE60208562T2/en not_active Expired - Fee Related
- 2002-07-15 ES ES02750839T patent/ES2256500T3/en not_active Expired - Lifetime
- 2002-07-15 EP EP02750839A patent/EP1407037B1/en not_active Expired - Lifetime
- 2002-07-15 AR ARP020102632A patent/AR036169A1/en active IP Right Grant
- 2002-07-15 KR KR1020047000641A patent/KR100697762B1/en not_active IP Right Cessation
- 2002-07-15 BR BR0211148-9A patent/BR0211148A/en not_active IP Right Cessation
- 2002-07-15 AU AU2002354844A patent/AU2002354844B2/en not_active Ceased
- 2002-07-15 WO PCT/DK2002/000497 patent/WO2003008617A1/en active IP Right Grant
- 2002-07-15 DK DK02750839T patent/DK1407037T3/en active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1407037B1 (en) | Process for manufacturing of tagatose | |
AU2002354844A1 (en) | Process for manufacturing of tagatose | |
Oliveira et al. | Recombinant microbial systems for improved β-galactosidase production and biotechnological applications | |
RU2451688C2 (en) | Method of producing tagatose using soya oligosaccharide | |
US6057135A (en) | Process for manufacturing D-tagatose | |
US8173399B2 (en) | Method for producing lacto-N-biose I and galacto-N-biose | |
US6991923B2 (en) | Process for manufacturing of tagatose | |
Van de Voorde et al. | Evaluation of the cold-active Pseudoalteromonas haloplanktis β-galactosidase enzyme for lactose hydrolysis in whey permeate as primary step of d-tagatose production | |
CN102443578B (en) | Glucose isomerase mutant and application thereof | |
FI79557B (en) | FOERFARANDE FOER ISOMERISERING AV GLUKOS TILL FRUKTOS. | |
Yoshida et al. | Production of trehalose by a dual enzyme system of immobilized maltose phosphorylase and trehalose phosphorylase | |
US7052898B2 (en) | Thermostable isomerase and use hereof, in particular for producing tagatose | |
US6933138B2 (en) | Thermostable L-arabinose isomerase and process for preparing D-tagatose | |
KR100443865B1 (en) | Thermostable L-Arabinose Isomerase and Process for Preparing D-tagatose thereby | |
EP1407038B1 (en) | A thermostable isomerase and use thereof, in particular for producing tagatose | |
ZA200400088B (en) | Process for manufacturing of tagatose. | |
US5219751A (en) | Xylase isomerase purified from thermotoga maritima and thermotoga neapolitana | |
NO320145B1 (en) | Process for the preparation of tagatose | |
EP4431613A1 (en) | Method for the production of d-tagatose using an l-arabinose isomerase from lentilactobacillus parakefiri | |
AU2002328273B2 (en) | A thermostable isomerase and use thereof in particular for producing tagatose | |
KR20200047176A (en) | Method for preparing turanose | |
CN117305204A (en) | Method for producing D-tagatose by whole cell catalysis and application thereof | |
AU2002328273A1 (en) | A thermostable isomerase and use thereof in particular for producing tagatose | |
PL216683B1 (en) | Process for the preparation of D-tagatose from lactose using a recombinant yeast strain Pichia pastoris producing �-D-galactosidase, Arthrobacter chlorophenolicus and arabinose isomerase Arthrobacter sp.22c |